LiBBY trial results show THC-CBD combo significantly reduces end-of-life dementia agitation
A Phase 2 randomized, double-blind, placebo-controlled trial suggests that a cannabinoid combination of THC and CBD can rapidly and substantially reduce agitation in hospice-eligible people...















